Key Takeaways
- Credo Technology fell 6% this morning, along with Marvell, Lumentum, Coherent and Astera Labs, as Nvidia’s troubles weighed on AI suppliers.
- Stifel cut its target to $250 but still expects Credo to beat and raise on Dec. 1.
- Analysts expect Credo’s normalized EPS to nearly triple by fiscal 2028, while its forward P/E sits near a 3-year low.
- The selling looks overdone, and the Dec. 1 report is the test.
Credo Technology (CRDO) sank 6% this morning on someone else’s news.
After Thursday’s close, California’s attorney general subpoenaed Nvidia over whether its chips or confidential information reached China and whether it misled investors.
CNBC’s Jim Cramer said: “The bad news from Nvidia, the most important knowledge generating company, is overwhelming the good news” of Anthropic’s record IPO. The selling hit the companies that connect AI chips: Marvell Technology (MRVL), Astera Labs (ALAB), and optical suppliers Lumentum (LITE) and Coherent (COHR).
Stifel still expects a beat
Stifel cut its Credo target this morning, to $250 from $310, but kept its Buy rating and expects a beat and raise on strength in its active electrical cables and optics. Analysts see earnings climbing fast:

On fiscal 2028’s $9.71, Stifel’s $250 is about 26x earnings. Credo closed Thursday at 16x forward earnings, against a 3-year average of 61x:

At today’s price, it’s about 15x, right around the low it set on Nov. 5.
TIKR tracks 20 analysts on Credo Technology. How many say “Buy”?
See the full breakdown of Buy, Hold, and Sell ratings on Credo Technology, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See Credo Technology’s Analyst Ratings
Everyone’s in the same boat
Marvell fell 5%. On Nov. 17, it settled its cable patent dispute with Credo. It also reports on Dec. 1, so its view on copper and optics lands the same evening as Credo’s numbers.
Lumentum fell 7%, and its shares now track Marvell’s since Marvell agreed on Nov. 2 to buy it in an all-stock deal valued at $115 billion, a bet on optics. Coherent also fell 6% with no news of its own, though Marvell’s bet on optics covers its market too.
Astera Labs fell 6%, weeks after guiding fourth-quarter revenue to $730 million-$750 million, up from a record $584.9 million in the third quarter.
Credo looks oversold
Credo has real risks, such as MaxLinear going after 20% to 30% of next-generation cables, but today’s selling has nothing to do with them. That looks overdone to me.
Credo reports after the close on Dec. 1. It needs at least $1.46 billion in fiscal 2027’s second half to reach its target of more than 85% growth. A big step up in its third-quarter guide would back the case.
So what is Credo stock actually worth?
TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what Credo could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!